Clear Street Group Inc. Purchases Shares of 60,000 Kenvue Inc. $KVUE

Clear Street Group Inc. purchased a new stake in Kenvue Inc. (NYSE:KVUE) during the 4th quarter, Holdings Channel reports. The firm purchased 60,000 shares of the company’s stock, valued at approximately $1,035,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Arax Advisory Partners increased its stake in Kenvue by 219.7% in the 4th quarter. Arax Advisory Partners now owns 4,463 shares of the company’s stock valued at $77,000 after buying an additional 3,067 shares during the last quarter. Aigen Investment Management LP increased its position in shares of Kenvue by 58.5% during the 4th quarter. Aigen Investment Management LP now owns 179,042 shares of the company’s stock worth $3,088,000 after purchasing an additional 66,052 shares during the last quarter. Kestra Advisory Services LLC increased its position in shares of Kenvue by 4.2% during the 4th quarter. Kestra Advisory Services LLC now owns 173,807 shares of the company’s stock worth $2,998,000 after purchasing an additional 6,998 shares during the last quarter. Transamerica Financial Advisors LLC increased its position in shares of Kenvue by 80.4% during the 4th quarter. Transamerica Financial Advisors LLC now owns 11,083 shares of the company’s stock worth $191,000 after purchasing an additional 4,939 shares during the last quarter. Finally, Marshall Wace LLP raised its stake in shares of Kenvue by 560.2% during the 4th quarter. Marshall Wace LLP now owns 5,826,776 shares of the company’s stock worth $100,512,000 after purchasing an additional 4,944,173 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on KVUE shares. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Barclays cut their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Weiss Ratings downgraded Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Argus raised shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Finally, Citigroup decreased their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $19.33.

Kenvue Stock Performance

Shares of KVUE opened at $18.13 on Monday. The firm has a 50-day moving average of $17.43 and a 200-day moving average of $17.54. Kenvue Inc. has a one year low of $14.02 and a one year high of $22.87. The company has a market cap of $34.80 billion, a PE ratio of 21.32, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter last year, the firm posted $0.24 EPS. The company’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Insider Activity at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.59% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.